This section contains information intended for healthcare professionals. Please certify that you are a healthcare professional.

Please indicate your country of residence:

What language is your preference?

Welcome to our new Sebia website!
Extranet
  • Pathologies
    • Oncology
      • Multiple Myeloma
    • Metabolic Diseases
      • Diabetes
      • Chronic Alcohol Abuse
    • Genetic Diseases
      • Hemoglobin Disorders
      • Alpha-1 Antitrypsin Deficiency
    • Autoimmune & Inflammatory Diseases
      • Central Nervous System Inflammatory Disease
  • Technologies
    • Capillary Electrophoresis
    • Gel Electrophoresis
  • Solutions
    • Instruments
    • Tests
    • Software
    • Sebia Workflow Service
    • Sebia Academy
  • Resources
  • Sebia
    • Company Overview
    • Worldwide presence
    • Research & Innovation
    • Quality & Compliance
    • Sustainability
    • Join us
  • Extranet
  • en
  • en
  • Pathologies
    • Oncology
      • Multiple Myeloma
    • Metabolic Diseases
      • Diabetes
      • Chronic Alcohol Abuse
    • Genetic Diseases
      • Hemoglobin Disorders
      • Alpha-1 Antitrypsin Deficiency
    • Autoimmune & Inflammatory Diseases
      • Central Nervous System Inflammatory Disease
  • Technologies
    • Capillary Electrophoresis
    • Gel Electrophoresis
  • Solutions
    • Instruments
    • Tests
    • Software
    • Sebia Workflow Service
    • Sebia Academy
  • Resources
  • Sebia
    • Company Overview
    • Worldwide presence
    • Research & Innovation
    • Quality & Compliance
    • Sustainability
    • Join us
  • Homepage
  • Resources
  • AACC 2022

AACC 2022

Event Multiple Myeloma Hemoglobin Disorders Diabetes
Published 06.10.2022 - Last update 06.15.2022


  • Contact us
  • Privacy policy
  • Legal notice
  • Change country
Newsletter
Subscribe
Follow us

© Sebia 2023 – Website creation: Adveris